US › Healthcare

CryoCell International Inc (CCEL)

US · Healthcare · Medical Care Facilities

$4.25-3.63%

Last close · 2026-09-17

Latest quarter · ended 2026-05-31

Revenue

$7.8M

Revenue YoY

-1.9%

Net profit

$554,586

Profit YoY

+55.9%

EPS

$0.07

Net margin

7.1%

Key statistics

Market cap

$35.5M

Forward P/E

2,000.0

P/B

9.72

Book value

$-2.20

EPS (TTM)

$-0.31

52-week high

$5.00

52-week low

$2.72

50-day MA

$3.77

200-day MA

$3.58

Beta

0.55

Analyst view

Analysts rate CryoCell International Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.50.

Shareholding

Insiders

34.59%

Institutions

13.72%

Largest institutional holders

Fund	Stake
SFI Advisors, LLC	2.05%
Vanguard Capital Management, LLC	2.00%
MASSMUTUAL TRUST CO FSB/ADV	1.38%
Geode Capital Management, LLC	0.54%
Vanguard Fiduciary Trust Co	0.29%
BlackRock Inc	0.17%
Susquehanna International Group, LLP	0.12%
Advisor Group Holdings, Inc.	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CryoCell International Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.